Guardant Health (GH) Competitors

Guardant Health logo
$145.07 +1.05 (+0.73%)
As of 02:36 PM Eastern
This is a fair market value price provided by Massive. Learn more.

GH vs. CI, LH, DGX, BTSG, and TEM

Should you buy Guardant Health stock or one of its competitors? Guardant Health's main competitors and comparable companies include Cigna Group (CI), Labcorp (LH), Quest Diagnostics (DGX), BrightSpring Health Services (BTSG), and Tempus AI (TEM). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Guardant Health compare to Cigna Group?

Cigna Group (NYSE:CI) and Guardant Health (NASDAQ:GH) are both large-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, profitability, dividends, risk, analyst recommendations and media sentiment.

Cigna Group has a net margin of 2.09% compared to Guardant Health's net margin of -37.93%. Cigna Group's return on equity of 19.57% beat Guardant Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Cigna Group2.09% 19.57% 5.35%
Guardant Health -37.93%N/A -25.03%

87.0% of Cigna Group shares are held by institutional investors. Comparatively, 92.6% of Guardant Health shares are held by institutional investors. 0.6% of Cigna Group shares are held by insiders. Comparatively, 5.6% of Guardant Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Cigna Group currently has a consensus price target of $336.90, suggesting a potential upside of 12.34%. Guardant Health has a consensus price target of $190.88, suggesting a potential upside of 32.53%. Given Guardant Health's stronger consensus rating and higher possible upside, analysts clearly believe Guardant Health is more favorable than Cigna Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cigna Group
0 Sell rating(s)
8 Hold rating(s)
14 Buy rating(s)
0 Strong Buy rating(s)
2.64
Guardant Health
1 Sell rating(s)
0 Hold rating(s)
24 Buy rating(s)
1 Strong Buy rating(s)
2.96

In the previous week, Cigna Group had 8 more articles in the media than Guardant Health. MarketBeat recorded 24 mentions for Cigna Group and 16 mentions for Guardant Health. Cigna Group's average media sentiment score of 0.70 beat Guardant Health's score of 0.13 indicating that Cigna Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cigna Group
10 Very Positive mention(s)
1 Positive mention(s)
8 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
Guardant Health
2 Very Positive mention(s)
0 Positive mention(s)
9 Neutral mention(s)
2 Negative mention(s)
1 Very Negative mention(s)
Neutral

Cigna Group has a beta of 0.25, meaning that its stock price is 75% less volatile than the broader market. Comparatively, Guardant Health has a beta of 1.67, meaning that its stock price is 67% more volatile than the broader market.

Cigna Group has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Cigna Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cigna Group$274.90B0.29$5.96B$22.6613.23
Guardant Health$982.02M19.84-$416.28M-$3.68N/A

Summary

Cigna Group beats Guardant Health on 9 of the 17 factors compared between the two stocks.

How does Guardant Health compare to Labcorp?

Labcorp (NYSE:LH) and Guardant Health (NASDAQ:GH) are both large-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, dividends, valuation, media sentiment, earnings, risk, analyst recommendations and profitability.

Labcorp currently has a consensus target price of $369.08, suggesting a potential downside of 0.89%. Guardant Health has a consensus target price of $190.88, suggesting a potential upside of 32.53%. Given Guardant Health's stronger consensus rating and higher probable upside, analysts plainly believe Guardant Health is more favorable than Labcorp.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Labcorp
0 Sell rating(s)
3 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.83
Guardant Health
1 Sell rating(s)
0 Hold rating(s)
24 Buy rating(s)
1 Strong Buy rating(s)
2.96

95.9% of Labcorp shares are owned by institutional investors. Comparatively, 92.6% of Guardant Health shares are owned by institutional investors. 0.8% of Labcorp shares are owned by company insiders. Comparatively, 5.6% of Guardant Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Labcorp has a beta of 0.86, meaning that its stock price is 14% less volatile than the broader market. Comparatively, Guardant Health has a beta of 1.67, meaning that its stock price is 67% more volatile than the broader market.

Labcorp has a net margin of 6.88% compared to Guardant Health's net margin of -37.93%. Labcorp's return on equity of 17.13% beat Guardant Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Labcorp6.88% 17.13% 7.96%
Guardant Health -37.93%N/A -25.03%

Labcorp has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Labcorp, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Labcorp$13.95B2.17$876.50M$12.1930.55
Guardant Health$982.02M19.84-$416.28M-$3.68N/A

In the previous week, Guardant Health had 5 more articles in the media than Labcorp. MarketBeat recorded 16 mentions for Guardant Health and 11 mentions for Labcorp. Labcorp's average media sentiment score of 0.34 beat Guardant Health's score of 0.13 indicating that Labcorp is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Labcorp
4 Very Positive mention(s)
0 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Guardant Health
2 Very Positive mention(s)
0 Positive mention(s)
9 Neutral mention(s)
2 Negative mention(s)
1 Very Negative mention(s)
Neutral

Summary

Labcorp beats Guardant Health on 9 of the 16 factors compared between the two stocks.

How does Guardant Health compare to Quest Diagnostics?

Quest Diagnostics (NYSE:DGX) and Guardant Health (NASDAQ:GH) are both large-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, media sentiment, valuation, risk, analyst recommendations and dividends.

88.1% of Quest Diagnostics shares are held by institutional investors. Comparatively, 92.6% of Guardant Health shares are held by institutional investors. 0.9% of Quest Diagnostics shares are held by company insiders. Comparatively, 5.6% of Guardant Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Quest Diagnostics has a beta of 0.55, indicating that its share price is 45% less volatile than the broader market. Comparatively, Guardant Health has a beta of 1.67, indicating that its share price is 67% more volatile than the broader market.

Quest Diagnostics has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Quest Diagnostics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Quest Diagnostics$11.04B2.61$992M$10.0426.06
Guardant Health$982.02M19.84-$416.28M-$3.68N/A

Quest Diagnostics has a net margin of 9.53% compared to Guardant Health's net margin of -37.93%. Quest Diagnostics' return on equity of 16.21% beat Guardant Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Quest Diagnostics9.53% 16.21% 7.41%
Guardant Health -37.93%N/A -25.03%

In the previous week, Quest Diagnostics had 12 more articles in the media than Guardant Health. MarketBeat recorded 28 mentions for Quest Diagnostics and 16 mentions for Guardant Health. Quest Diagnostics' average media sentiment score of 0.22 beat Guardant Health's score of 0.13 indicating that Quest Diagnostics is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Quest Diagnostics
5 Very Positive mention(s)
3 Positive mention(s)
4 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
Guardant Health
2 Very Positive mention(s)
0 Positive mention(s)
9 Neutral mention(s)
2 Negative mention(s)
1 Very Negative mention(s)
Neutral

Quest Diagnostics presently has a consensus target price of $248.70, suggesting a potential downside of 4.96%. Guardant Health has a consensus target price of $190.88, suggesting a potential upside of 32.53%. Given Guardant Health's stronger consensus rating and higher probable upside, analysts clearly believe Guardant Health is more favorable than Quest Diagnostics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Quest Diagnostics
0 Sell rating(s)
5 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.56
Guardant Health
1 Sell rating(s)
0 Hold rating(s)
24 Buy rating(s)
1 Strong Buy rating(s)
2.96

Summary

Quest Diagnostics beats Guardant Health on 9 of the 16 factors compared between the two stocks.

How does Guardant Health compare to BrightSpring Health Services?

BrightSpring Health Services (NASDAQ:BTSG) and Guardant Health (NASDAQ:GH) are both large-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, media sentiment, profitability, institutional ownership and valuation.

BrightSpring Health Services has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BrightSpring Health Services$12.91B1.10$190.67M$1.8538.58
Guardant Health$982.02M19.84-$416.28M-$3.68N/A

BrightSpring Health Services has a beta of 1.77, indicating that its stock price is 77% more volatile than the broader market. Comparatively, Guardant Health has a beta of 1.67, indicating that its stock price is 67% more volatile than the broader market.

BrightSpring Health Services has a net margin of 2.69% compared to Guardant Health's net margin of -37.93%. BrightSpring Health Services' return on equity of 18.56% beat Guardant Health's return on equity.

Company Net Margins Return on Equity Return on Assets
BrightSpring Health Services2.69% 18.56% 6.03%
Guardant Health -37.93%N/A -25.03%

BrightSpring Health Services currently has a consensus target price of $77.81, indicating a potential upside of 9.03%. Guardant Health has a consensus target price of $190.88, indicating a potential upside of 32.53%. Given Guardant Health's higher probable upside, analysts plainly believe Guardant Health is more favorable than BrightSpring Health Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BrightSpring Health Services
0 Sell rating(s)
0 Hold rating(s)
17 Buy rating(s)
2 Strong Buy rating(s)
3.11
Guardant Health
1 Sell rating(s)
0 Hold rating(s)
24 Buy rating(s)
1 Strong Buy rating(s)
2.96

In the previous week, Guardant Health had 9 more articles in the media than BrightSpring Health Services. MarketBeat recorded 16 mentions for Guardant Health and 7 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 0.97 beat Guardant Health's score of 0.13 indicating that BrightSpring Health Services is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BrightSpring Health Services
3 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Guardant Health
2 Very Positive mention(s)
0 Positive mention(s)
9 Neutral mention(s)
2 Negative mention(s)
1 Very Negative mention(s)
Neutral

92.6% of Guardant Health shares are owned by institutional investors. 2.8% of BrightSpring Health Services shares are owned by company insiders. Comparatively, 5.6% of Guardant Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

BrightSpring Health Services beats Guardant Health on 11 of the 17 factors compared between the two stocks.

How does Guardant Health compare to Tempus AI?

Guardant Health (NASDAQ:GH) and Tempus AI (NASDAQ:TEM) are both large-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, analyst recommendations, media sentiment, dividends, risk, institutional ownership and earnings.

92.6% of Guardant Health shares are held by institutional investors. Comparatively, 24.2% of Tempus AI shares are held by institutional investors. 5.6% of Guardant Health shares are held by insiders. Comparatively, 24.3% of Tempus AI shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Guardant Health has a beta of 1.67, meaning that its stock price is 67% more volatile than the broader market. Comparatively, Tempus AI has a beta of 3.61, meaning that its stock price is 261% more volatile than the broader market.

Tempus AI has a net margin of -12.54% compared to Guardant Health's net margin of -37.93%. Guardant Health's return on equity of 0.00% beat Tempus AI's return on equity.

Company Net Margins Return on Equity Return on Assets
Guardant Health-37.93% N/A -25.03%
Tempus AI -12.54%-47.00%-9.44%

In the previous week, Guardant Health had 4 more articles in the media than Tempus AI. MarketBeat recorded 16 mentions for Guardant Health and 12 mentions for Tempus AI. Tempus AI's average media sentiment score of 0.65 beat Guardant Health's score of 0.13 indicating that Tempus AI is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Guardant Health
2 Very Positive mention(s)
0 Positive mention(s)
9 Neutral mention(s)
2 Negative mention(s)
1 Very Negative mention(s)
Neutral
Tempus AI
5 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Positive

Tempus AI has higher revenue and earnings than Guardant Health. Tempus AI is trading at a lower price-to-earnings ratio than Guardant Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Guardant Health$982.02M19.84-$416.28M-$3.68N/A
Tempus AI$1.27B9.29-$245.03M-$1.06N/A

Guardant Health presently has a consensus price target of $190.88, indicating a potential upside of 32.53%. Tempus AI has a consensus price target of $79.37, indicating a potential upside of 22.56%. Given Guardant Health's stronger consensus rating and higher probable upside, equities research analysts clearly believe Guardant Health is more favorable than Tempus AI.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Guardant Health
1 Sell rating(s)
0 Hold rating(s)
24 Buy rating(s)
1 Strong Buy rating(s)
2.96
Tempus AI
1 Sell rating(s)
10 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.45

Summary

Guardant Health beats Tempus AI on 9 of the 17 factors compared between the two stocks.

Get Guardant Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for GH and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GH vs. The Competition

MetricGuardant HealthHealthcare Providers & Services IndustryHealthcare SectorNASDAQ Exchange
Market Cap$19.43B$10.66B$7.76B$11.63B
Dividend YieldN/A2.54%2.46%4.43%
P/E Ratio-39.0235.9934.2929.91
Price / Sales19.802.088.485.64
Price / CashN/A23.3421.9322.50
Price / Book-70.453.604.393.67
Net Income-$416.28M$332.46M$3.51B$392.03M
7 Day Performance-7.49%-3.67%-5.19%-3.98%
1 Month Performance-9.39%-1.36%-4.33%-6.46%
1 Year Performance48.95%19.27%-1.33%-6.95%

Guardant Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GH
Guardant Health
3.8424 of 5 stars
$145.08
+0.7%
$190.88
+31.6%
+52.6%$19.59B$982.02MN/A2,506
CI
Cigna Group
4.7358 of 5 stars
$295.37
+0.6%
$336.20
+13.8%
+11.3%$80.70B$274.90B9.7067,700
LH
Labcorp
2.9718 of 5 stars
$371.68
+1.4%
$369.08
-0.7%
+39.6%$29.86B$13.95B20.3371,000
DGX
Quest Diagnostics
3.6776 of 5 stars
$259.28
+1.4%
$248.70
-4.1%
+40.0%$28.13B$11.04B23.1657,000
BTSG
BrightSpring Health Services
3.6946 of 5 stars
$69.15
+3.0%
$77.81
+12.5%
+123.0%$13.89B$12.91B37.3823,500

Related Companies and Tools


This page (NASDAQ:GH) was last updated on 11/17/2026 by MarketBeat.com Staff.
From Our Partners